Studies on nStudies on neutralizing anti-heparin-binding epidermal growth factor-like growth factor (HB-EGF) antibodies for drug development of cancer treatmentShuji Sato(Obihiro National Hospital)Institutional Repositories DataBase (IRDB)January 1, 200010.15083/00005449Cited by 0SaveCiteExport RISWatch citationsRelated PapersIsolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.|PubMed|2000|30Identification of the Cancer Cell Proliferation and Survival Functions of proHB-EGF by Using an Anti-HB-EGF Antibody|PLoS ONE|2013|11